Results 171 to 180 of about 154,096 (287)

Oral Deucravacitinib for Treatment-Refractory Cutaneous Lupus Erythematosus. [PDF]

Cureus
Matthew EJ, Verma KK, Paulger B.
europepmc   +1 more source

A Diagnostic Conundrum: Unusual Presentation of Acute Cutaneous Lupus Erythematosus Mimicking Toxic Epidermal Necrolysis. [PDF]

Eur J Rheumatol
Kamble N, Khot R, Barai S, Chaudhari S, Rathod B, Awadhiya O.   +5 more
europepmc   +1 more source

Comedonal Plaques With Scarring Alopecia on the Scalp: A Case Report. [PDF]

Cureus
Sharma A, K B M, Chatterjee D, Kumaran MS.   +3 more
europepmc   +1 more source

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

, 2020
Bathon, J., Breedveld, F., Burmester, G., Bykerk, V., Crofford, L., Cronstein, B., Dougados, M., Furst, D., Kalden, J., Mariette, X., Mease, P., Melchers, F., Rosenbaum, J., Sieper, J., Smolen, J., Weinblatt, M., Winthrop, K.   +16 more
core   +1 more source

A case of pulmonary and cutaneous sarcoidosis. [PDF]

Breathe (Sheff)
Foley E, Basirat A, Yadav A, O'Brien S, Mitchell PD, Donnelly SC.   +5 more
europepmc   +1 more source

Refractory Dermatitis Evolving Into Lupus Spectrum Disease in the Setting of Dupilumab Use. [PDF]

Cureus
Joseph JM, Kilgore J, Culotta N.
europepmc   +1 more source

A Triple Threat: Acute Systemic Lupus Erythematosus Unveiled with Hemophagocytic Lymphohistiocytosis and Toxic Epidermal Necrolysis. [PDF]

J Brown Hosp Med
Shah C, Cotter L, Yu E, Wanat K, Harrington A, Sabchyshyn V, Umpierrez A.   +6 more
europepmc   +1 more source

Hypertrophic lupus erythematosus hypertrophic lichen planus overlap responding to acitretin and anifrolumab. [PDF]

JAAD Case Rep
Hojjatie RA, Flickinger B, Stuart LN, Caudell MD.   +3 more
europepmc   +1 more source

Flare of bullous lupus erythematosus in patients treated with anifrolumab for discoid lupus erythematosus: 2 cases. [PDF]

JAAD Case Rep
Lesort C, Breton AL, Wirbel C, Durel CA, Chastagner M, Ribereau-Gayon E, Hot A, Kanitakis J.   +7 more
europepmc   +1 more source

Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy. [PDF]

Front Immunol
Bao H, Zhang J, Luo X, Song X, Li J, Mao N, Chen F, Bao H, Hu J, Cao X, Ma S, Lin L.   +11 more
europepmc   +1 more source